Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $700.17 | 25 | 92.8% |
| Education | $54.24 | 2 | 7.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $216.42 | 4 | $0 (2024) |
| Genentech USA, Inc. | $166.95 | 4 | $0 (2019) |
| GlaxoSmithKline, LLC. | $162.27 | 4 | $0 (2022) |
| Insmed, Inc. | $52.51 | 3 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $49.62 | 6 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $48.82 | 3 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $42.42 | 2 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.40 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $120.62 | 1 | INTUITIVE SURGICAL, INC. ($120.62) |
| 2023 | $95.80 | 3 | Intuitive Surgical, Inc. ($95.80) |
| 2022 | $14.25 | 1 | GlaxoSmithKline, LLC. ($14.25) |
| 2021 | $118.29 | 6 | Insmed, Inc. ($52.51) |
| 2020 | $66.49 | 4 | AstraZeneca Pharmaceuticals LP ($28.82) |
| 2019 | $134.52 | 3 | GlaxoSmithKline, LLC. ($122.39) |
| 2018 | $138.11 | 2 | Genentech USA, Inc. ($138.11) |
| 2017 | $66.33 | 7 | Sunovion Pharmaceuticals Inc. ($49.62) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/30/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $120.62 | General |
| Category: SURGERY | ||||||
| 08/15/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $47.04 | General |
| Category: SURGERY | ||||||
| 08/15/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $39.51 | General |
| Category: SURGERY | ||||||
| 07/25/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: SURGERY | ||||||
| 08/10/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: IMMUNOLOGY | ||||||
| 07/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV, OFEV | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Respiratory | ||||||
| 05/25/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Respiratory | ||||||
| 04/29/2021 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: Respiratory | ||||||
| 03/17/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Respiratory | ||||||
| 03/17/2021 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 12/09/2020 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Respiratory | ||||||
| 10/06/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Respiratory | ||||||
| 02/20/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: RESPIRATORY | ||||||
| 01/14/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Respiratory | ||||||
| 12/18/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $104.25 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2019 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Immunology | ||||||
| 09/13/2018 | Genentech USA, Inc. | Esbriet (Biological) | Education | In-kind items and services | $38.00 | General |
| Category: Immunology | ||||||
| 08/21/2018 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $100.11 | General |
| Category: Immunology | ||||||
| 08/25/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Immunology | ||||||
| 08/18/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: RESPIRATORY | ||||||
| 07/14/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: RESPIRATORY | ||||||
| 06/16/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: RESPIRATORY | ||||||
| 06/16/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,666 | 1,944 | $725,404 | $152,009 |
| 2022 | 11 | 1,339 | 1,506 | $545,562 | $119,548 |
| 2021 | 11 | 1,236 | 1,406 | $429,778 | $96,406 |
| 2020 | 12 | 1,170 | 1,295 | $479,910 | $86,587 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 306 | 456 | $232,560 | $55,049 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 367 | 483 | $168,084 | $38,961 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 158 | 158 | $124,662 | $24,910 | 20.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 221 | 221 | $114,036 | $22,293 | 19.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 47 | 51 | $16,677 | $3,883 | 23.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 178 | 181 | $10,498 | $1,964 | 18.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 15 | 15 | $7,110 | $1,838 | 25.9% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 183 | 186 | $7,812 | $1,528 | 19.6% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 115 | 117 | $20,709 | $911.40 | 4.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 76 | 76 | $23,256 | $671.38 | 2.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 265 | $135,150 | $31,284 | 23.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 232 | 232 | $119,712 | $25,898 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 232 | 296 | $103,008 | $25,470 | 24.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 137 | 172 | $56,244 | $14,643 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 78 | 78 | $61,542 | $13,095 | 21.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 37 | 41 | $19,434 | $4,996 | 25.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 127 | 127 | $7,366 | $1,523 | 20.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 132 | 132 | $5,544 | $1,174 | 21.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 86 | 86 | $15,222 | $704.63 | 4.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 64 | 64 | $19,584 | $643.46 | 3.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 13 | $2,756 | $117.60 | 4.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 226 | 301 | $104,748 | $26,435 | 25.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 259 | 335 | $71,020 | $17,688 | 24.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 128 | 128 | $66,048 | $13,911 | 21.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 89 | 102 | $52,020 | $13,316 | 25.6% |
About Dr. Gregory Gerboth, MD
Dr. Gregory Gerboth, MD is a Pulmonary Disease healthcare provider based in Anchorage, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407838170.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Gerboth, MD has received a total of $754.41 in payments from pharmaceutical and medical device companies, with $120.62 received in 2024. These payments were reported across 27 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($700.17).
As a Medicare-enrolled provider, Gerboth has provided services to 5,411 Medicare beneficiaries, totaling 6,151 services with total Medicare billing of $454,550. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Anchorage, AK
- Active Since 11/17/2005
- Last Updated 09/23/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1407838170
Products in Payments
- Da Vinci Surgical System (Device) $216.42
- Esbriet (Biological) $154.82
- TRELEGY ELLIPTA (Drug) $104.25
- NUCALA (Biological) $58.02
- Arikayce (Drug) $52.51
- AirDuo Digihaler (Drug) $42.42
- BROVANA (Drug) $35.19
- BREZTRI (Drug) $20.00
- BREZTRI AEROSPHERE (Drug) $16.01
- OFEV (Drug) $15.40
- UTIBRON (Drug) $14.43
- SYMBICORT (Drug) $12.81
- Xolair (Biological) $12.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Anchorage
Marek Martynowicz, Md, MD
Pulmonary Disease — Payments: $13,937
John Clark, Md, MD
Pulmonary Disease — Payments: $1,122
Beth Baker, Md, MD
Pulmonary Disease — Payments: $796.55
Denise Wurth, Md, MD
Pulmonary Disease — Payments: $421.14
David Zielke, Md, MD
Pulmonary Disease — Payments: $120.58
Dr. David Frankl, M.d., M.p.h, M.D., M.P.H
Pulmonary Disease — Payments: $67.76